Orbifloxacin D4 | CAS 2714415-07-1 - Request Quote
Orbifloxacin D4
| SZ CAT No: | SZ-O024D01 |
| CAS No | 2714415-07-1 |
| Mol.F. | C19H16D4F3N3O3 |
| Mol.Wt. |
399.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Orbifloxacin D4 is chemically 1-(cyclopropyl-2,2,3,3-d4)-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. Orbifloxacin D4 is supplied with detailed characterization data compliant with regulatory guideline. Orbifloxacin D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Orbifloxacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2714415-07-1
Purchase 2714415-07-1
Order 2714415-07-1
Enquire 2714415-07-1
price of 2714415-07-1
2714415-07-1 Supplier
2714415-07-1 Manufacturer
2714415-07-1 Exporter
buy high quality Orbifloxacin D4
Purchase Orbifloxacin D4
Orbifloxacin D4 suppliers
Orbifloxacin D4 manufacturers
Orbifloxacin D4 price
Order Orbifloxacin D4
Enquire Orbifloxacin D4
Orbifloxacin D4 cost
Orbifloxacin D4 Supplier
Orbifloxacin D4 Distributor
Orbifloxacin D4 for Method Validation
Orbifloxacin Reference Standard
Orbifloxacin D4 for ANDA Filing
Orbifloxacin D4 for Forced Degradation Studies
Orbifloxacin D4 Identification Standards
Orbifloxacin D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.